These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 36314264)
1. Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches. Merino-Vico A; Frazzei G; van Hamburg JP; Tas SW Eur J Immunol; 2023 Jan; 53(1):e2149675. PubMed ID: 36314264 [TBL] [Abstract][Full Text] [Related]
3. Selfie: Autoimmunity, boon or bane. Ahsan H J Immunoassay Immunochem; 2017; 38(3):235-246. PubMed ID: 28421864 [TBL] [Abstract][Full Text] [Related]
4. The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting. Baert L; Manfroi B; Casez O; Sturm N; Huard B J Autoimmun; 2018 Dec; 95():179-190. PubMed ID: 30385081 [TBL] [Abstract][Full Text] [Related]
7. [Autoantibodies and antibody-secreting cells]. Hiepe F; Dörner T Z Rheumatol; 2005 Sep; 64(6):389-95. PubMed ID: 16184346 [TBL] [Abstract][Full Text] [Related]
8. Targeting B Cells and Plasma Cells in Autoimmune Diseases. Hofmann K; Clauder AK; Manz RA Front Immunol; 2018; 9():835. PubMed ID: 29740441 [TBL] [Abstract][Full Text] [Related]
9. Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases-Implications for Therapeutic Approaches. Fetter T; Niebel D; Braegelmann C; Wenzel J Cells; 2020 Dec; 9(12):. PubMed ID: 33297481 [TBL] [Abstract][Full Text] [Related]
10. [B cell abnormalities and therapeutic strategies in systemic sclerosis]. Yoshizaki A Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935 [TBL] [Abstract][Full Text] [Related]
11. Beneficial autoimmunity participates in the regulation of rheumatoid arthritis. Zohar Y; Wildbaum G; Karin N Front Biosci; 2006 Jan; 11():368-79. PubMed ID: 16146738 [TBL] [Abstract][Full Text] [Related]
12. B Cell-Mediated Autoimmune Diseases. Lin X; Lu L Adv Exp Med Biol; 2020; 1254():145-160. PubMed ID: 32323275 [TBL] [Abstract][Full Text] [Related]
13. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells. Dörner T J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439 [TBL] [Abstract][Full Text] [Related]
15. Addressing the key issue: Antigen-specific targeting of B cells in autoimmune diseases. Holborough-Kerkvliet MD; Kroos S; van de Wetering R; Toes REM Immunol Lett; 2023 Jul; 259():37-45. PubMed ID: 37209914 [TBL] [Abstract][Full Text] [Related]
17. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum. Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917 [TBL] [Abstract][Full Text] [Related]
18. Age/autoimmunity-associated B cells in inflammatory arthritis: An emerging therapeutic target. Li ZY; Cai ML; Qin Y; Chen Z Front Immunol; 2023; 14():1103307. PubMed ID: 36817481 [TBL] [Abstract][Full Text] [Related]
19. Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target. Lou H; Ling GS; Cao X J Autoimmun; 2022 Oct; 132():102861. PubMed ID: 35872103 [TBL] [Abstract][Full Text] [Related]
20. The long and the short of it: insights into the cellular source of autoantibodies as revealed by B cell depletion therapy. Hale M; Rawlings DJ; Jackson SW Curr Opin Immunol; 2018 Dec; 55():81-88. PubMed ID: 30390507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]